SlideShare a Scribd company logo
1 of 7
Hafiz Choudhury
Email: hafizur.choudhury@outlook.com Mobile: 07837867759
KEYEXPERTISE
Regulatory Affairs skills: More than 10 years of Regulatory Affairs experience in CTA, OTC
products, MAA, International submissions, Variation, Renewals and License Maintenance and MA
transfers
Geographic experience: Europe,Asia, Latin America, Middle East and Africa
Therapeutic experience: Allergy & Respiratory, Cardiovascular, Metabolic, Hepatology,
Inflammation, Neuroscience, Oncology, and Pain
Professional experiences
RegulatoryAffairs Manager (consultant), PAREXELInternational, Uxbridge, UK
May 2015 – present
Main responsibilities
 Primarily acting as a Parexel Project Lead (PPL) to manage, facilitate and coordinate the
delivery of submissions within a given project timelines
 Responsible for regulatory submissions throughout the product life cycle globally – EU,
North Africa (FSA), Asia, Gulf & LATAM by coordinating with local teams
 The planning, coordination and oversight of all processes involved in gaining approvals
required in each country for a projects.
 Liaising directly with Health Authorities and third party vendors to support regulatory
application
 Coordinate collection of functional documents in support of regulatory applications
 Involved in Project forecasting, activity and submission trackers
 Provide regulatory support to Commercial, Medical and Clinical departments through cross-
functional interactions in brand and therapeutic area teams
 Responsible for the preparation and maintenance of labelling to support MAAs and other
post-licensing activities. Ensures that any updates to the Product CCDS are implemented in a
timely manner. Liaises with affiliates and/or third parties to co-ordinate translational
activities and the subsequent submission of language versions to HA.
 Liaises with regulatory, manufacturing and other parties as appropriate, to ensure that updates
to the product packaging components are implemented in line with approved labelling for
new MAAs or variations affecting the labeling, and in line with required timelines, for
products registered globally
 Liaises directly with local Affiliates, distributors or agents to define/clarify submission
requirements, and follow up on submissions, requests for supplementary information and
approvals with specific country and/or regional
Sanofi, Guildford, UK RegulatoryAffairs Manager (consultant)
August 2014 – April 2015
Main responsibilities
 Plan, participate and supervise the technical review and preparation of primary submissions
and variations to the MHRAand Ireland,
 Manage review and prepare,artwork changes for UK and Ireland i.e. in line with change of
ownership, site transfer
 Managed the review, preparation, submission and follow-up of regulatory submissions in the
UK,
 Managing the personal and professional development of colleagues within my team.
AMCo (Amdipharm Mercury Company Ltd) RegulatoryAffairs Manager (Consultant)
May 2012 –June 2014
Main responsibilities
 Management and preparation of rest of the world (ROW) technical and MAtransfers (non-
EU) + maintenance of established product licences.
 Review and preparation of the safety variations following critical findings from MHRA
inspections in UK,Ireland,
 Management and coordination of safety variation in EU and the rest of the world (ROW)
using affiliate’s and partners on establish products.
 Regulatory strategy, project manages regulatory submissions to agreed project targets.
 Provide operational regulatory input and guidance in cross-functional teams.
 Responsible for the preparation and maintenance of labelling to support MAAs and other
post-licensing activities. Ensures that any updates to the Product CCDS are implemented in a
timely manner. Liaises with affiliates and/or third parties to co-ordinate translational
activities and the subsequent submission of language versions to HA.
 Liaises with regulatory, manufacturing and other parties as appropriate, to ensure that updates
to the product packaging components are implemented in line with approved labelling for
new MAAs or variations affecting the labeling, and in line with required timelines, for
products registered globally
 Liaises directly with local Affiliates, distributors or agents to define/clarify submission
requirements, and follow up on submissions, requests for supplementary information and
approvals with specific country and/or regional
Pfizer Ltd, Surrey, UK RegulatoryAffairs Manager (Consultant)
September 2011 – May 2012
Main responsibilities
Manage and Submit Marketing AuthorisationApplications:
 National/MRP/Decentralised- Review, co-ordinate and create necessary technicaldata to
support UK/Irish submissions e.g. provide national specific module 1 data (PIL, labelling) and
module 3
 Review and approve proposed regulated documents (SPC, PIL,and Labelling) and associated
artwork in line with regulations.
 Submit Periodic Safety Update Reports to MHRAand IMB.
 Submit MA RenewalApplications
PRAinternational (CRO), Reading, UK Senior RegulatoryAffairs Consultant
June 2011 - September 2011
Main responsibilities
 Review promotional materials for compliance with relevant national and EU legislation and
codes of practice
 Participate in project team meetings and sponsor teleconferences for initiation activity
(regulatory and ethics approvals) as well as maintenance activity in the EU, non-EU countries
in Europe
 Preparing CTAfor Regulatory authority in EU and non EU-countries
Sinclair Pharmaceuticals Ltd, Guildford, UK Senior RegulatoryAffairs Consultant
August 2010 - May 2011
Main responsibility
 Managing MA transfers in EU,Asia and Mina countries,
 Managing the maintenance of license this include renewal, Type IA,B and type II variations
 Gap analysis
 Advising on other development projects and prospective pre-clinical and clinical data,which
may form parts of new IMPD,CTA.
 Reviewing labelling and Patient Information leaflets to ensure compliance with current
legislation for it to be released in the market
 Corresponding with the National health agencies e.g. MHRA,Afssaps and FAMHP
Reckitt Benckiser Healthcare,Hull, UK
Jan 2010 - July 2010
Senior RegulatoryAffairs Consultant
Main responsibility:
 Managing the maintenance of OTC license this include renewal,Type IA, B and type II variations
 Switch application
 Corresponding with the National health agencies e.g. MHRAand Irish Medicines Board
 Reviewing labelling and Patient Information leaflets to ensure compliance with current legislation
for it to be released in the market
 Review of documentations from departments outside Regulatory Affairs i.e. marketing, medical,
PV,manufacturing, Quality Assurance,Labelling, Operations functions and R&D. Provides advice
with applicable Department Director consultation as to regulatory acceptability of plans for drug
development and marketing of the product
 Ensuring consistency of readability testing, liaising with external groups (package user-tests
vendors), as appropriate.
RegulatoryAffairs Manager (consultant), Wyeth, Maidenhead, UK
Aug 09 - Dec 09
Main responsibility:
 Managed regulatory aspects of projects/products, including applications (CTA, renewals,variation
etc) submitted to regulatory agencies.
 Developed effective proactive regulatory strategies for global product development, CMC,
labelling or promotional issues, and recommends such strategies to RATeam Leader,Team
Members and/or supervisor, as appropriate with minor oversight.
 Interfaced directly with governmental regulatory personnel, including scientific reviewers,
administrative staff and management, to facilitate the review and approval of regulatory
applications. Plans and facilitates formal meetings and teleconferences with regulatory authorities.
 Reviewed of documentations from departments outside Regulatory Affairs. Provides moderate adv
ice with applicable Department Director consultation as to regulatory acceptability of plans for dru
g development, CMC, labelling or advertising/promotion through individual as well as RA Team a
nd Interdepartmental Project Team contacts.
Cephalon, Welwyn Garden City, UK
July 08 - July 09
Regulatory Affairs Manager (consultant)
Main responsibility:
 Prepared Type I and Type II variation applications, Licence renewalapplications,
 Approval of UK, Ireland, and EU artworks, change of ownership applications and general
regulatory
requests to MHRA, IMB etc
 Prepare,update and implement labels and leaflets to ensure compliance with marketing
authorisations
 Worked closely with functional areas throughout the company. Advises functional areas regarding
content requirements for regulatory submissions. Critically reviews documents from functional con
tributors for consistency and completeness
MDS Pharma Services, Winnersh, UK
Jan 08 - July 08
RegulatoryAffairs Manager (Consultant)
Main responsibilities:
 Prepare the clinical trial applications to support exploratory and full development programs,
ensuring the documentation meets relevant regulatory requirements. Worked with Clinical teams
and advised them on appropriate regulatory strategy when co-coordinating multi-centre clinical
trials including countries like Korea,India, Poland and Brazil
 Review promotional materials for compliance with relevant national and EU legislation and codes
of practice
 Participate in project team meetings and sponsor teleconferences for initiation activity (regulatory a
nd ethics approvals) as well as maintenance activity in the EU, non-EU countries in Europe, South
Africa,Asia and Latin America.
Ipsen, Slough Regulatory Affairs Manager (Consultant)
July 07 - Dec 07
Main responsibilities:
 General regulatory affairs activities as requested. This included post licensing activities including
variations Type I and II's. The preparation of clinical trial applications and liaising with regulatory
agencies to ensure compliance with requirements and responding to queries.
 Managed the EU registration procedures in EU (Centralised or Mutual Recognition)
 Prepared and compiled various sections of the CTD with specific emphasis to non-clinical sections
of CTD.
 Reviewed and commented on protocols/briefing books and reports relating to preclinical, clinical
and CMC development.
 Worked closely with functional areas throughout the company. Advises functional areas regarding
content requirements for regulatory submissions. Critically reviews documents from functional con
tributors for consistency and completeness
Biogen Idec,Maidenhead/Slough
January 07 - June 2007
Regulatory Affairs Manager (consultant)
Main responsibilities:
 Prepared and/or reviewed and/or submission of marketing authorization Application documents for
EU and International Markets (Asia and Latin America)
 Worked on development strategy with project teams to develop regulatory strategy for assigned
projects.
 Liaised with Contract Research Organisations for initial Regulatory submissions and follow-ups on
queries and Amendments. Preparation and/or review of standard operating procedures etc
I3 Research, Maidenhead, UK
Oct 2005 - Dec 2006
Senior Regulatory Affairs Associate
Main responsibilities:
Co-ordinate Regulatory and ethics submissions
 Define a regulatory strategy for the clinical trials.
 Provide sponsor/PM with a list of all regulatory documents required to make submissions.
 Review and prepare regulatory documents for submissions
 Arrange translations of regulatory documents as required
 Prepare and make Regulatory and Ethics submissions in coordination of the project team as required.
 Track submissions and approvals activities and updates to the Project Teams and Sponsors.
 Make submissions of Amendments, IB updates, annual reports etc. as requested by the Sponsors and
PM.
 Provide PM/Sponsor with regular regulatory status updates as required
 Arrange payments of Ethics Committees and Regulatory Authorities
 Ensure that regulatory approvals remain in compliance with their authorisations and with
current regulatory requirements. This includes scrutinising and making recommendations on
all relevant documents e.g. Labelling, patient information leaflets and data sheets to ensure
conformance with appropriate current requirements.
Foster constructive and professional working relationships with all contacts – internal and external – s
o that applications are submitted and approved expeditiously.
Sanofi-Aventis UK Regulatory Affairs Specialist
January 2005 - Oct 2005
Main responsibilities:
Managed company name change by preparing and submitting updated artwork components to the PIU
(Product Information Unit) for UK, Ireland and International Markets
 Preparation and submission of IA/B variation applications
 Preparation and submission of Marketing Authorisation Renewals
 Corresponding with the National health agencies e.g. MHRAand Irish Medicines Board
 Reviewing labelling and Patient Information leaflets to ensure compliance with current legislation.
 Maintaining and updating regulatory databases
 Producing technical files for products
Regulator-e-AssociatesLtd,
April 2004 - Dec 2004
Regulatory Affairs Associate
Main responsibilities:
 Prepared CMC dossiers including compliance and technical variations.
 Reviewed current pharmaceutical journals for day to day relevance to the business.
 Handled regulatory activities for our European clients.
 Reviewed all current European legislation regarding Clinical Trials Directive and putting together det
ailed intelligence documents for training programmes for the company.
Other Experiences
Over five years experience working within multinational pharmaceutical companies and academic
research institutions. I have acquired a strong background in pre-clinical neuropharmacology and
physiology during which time I have developed a high level of expertise in both in-vivo and in-vitro
experimental techniques.
MRI Neurology CEDD, GSK, UK Research Scientist
 Preparation of different models of neural disease states.
 Testing compounds for Alzheimer's, pain and stroke disease.
 Collaborating with various groups, and presented data to internal and externalgroups
 Planning, designing and setting up experimental biology studies.
Merck Sharp and Dohme, UK Research Scientist
 Electro-physiology group to screen candidate drug compounds using patch clamp.
 Tested compounds for various groups including pain, anaesthesiology and stroke.
 Report writing, and presentation of data to different department within the company.
Schering-Plough, UK Research Scientist
 Produced live vaccines within a GMP quality control facility.
Royal Free hospital & UCLMedical School, London Research Scientist
 Investigation of the baroreceptor reflex in the Nucleus Tractus Salaturas (NTS) and looked at c-fos ex
pression
Training courses attended
 Basics of Regulatory Affairs 21 June 2004
 Basic Expedition LeadersAward (BELA) November 2002- November 2003
o Planning and preparation method
o Instructional and organizational
o Navigation
o Leadership and party management
o Conservation and access
o First aid and emergencies
 Variation to Marketing Authorisation (MHRAcourse),4 April 2005
Education
1995 - 1999 University of Portsmouth, U.K.
BSc (Hons) Pharmacology
1993 - 1995 South-Thames College, U.K
BTEC National Diploma in Science
Other skills
 Skills in using various Regulatory Databases i.e. Novas, GDMS, Pfleet,HATS, GRS
 Fluent in English & Bengali
References
Available on request.

More Related Content

What's hot

Finnish biotech year, Tero Piispanen
Finnish biotech year, Tero Piispanen Finnish biotech year, Tero Piispanen
Finnish biotech year, Tero Piispanen Business Turku
 
5th Annual Pharmacovigilance (2010) Ts
5th Annual Pharmacovigilance (2010) Ts5th Annual Pharmacovigilance (2010) Ts
5th Annual Pharmacovigilance (2010) Tstatisalla
 
Nick Lawrence CV 2016 v2
Nick Lawrence CV 2016 v2Nick Lawrence CV 2016 v2
Nick Lawrence CV 2016 v2Nick Lawrence
 
Innovation drives expansion, Titus Gylvin
Innovation drives expansion, Titus Gylvin Innovation drives expansion, Titus Gylvin
Innovation drives expansion, Titus Gylvin Business Turku
 
Nick lawrence cv 2015 v1
Nick lawrence cv 2015 v1Nick lawrence cv 2015 v1
Nick lawrence cv 2015 v1Nick Lawrence
 
Tasso, Vanessa, resume, 6-15
Tasso, Vanessa, resume, 6-15Tasso, Vanessa, resume, 6-15
Tasso, Vanessa, resume, 6-15Vanessa Tasso
 
Clinical Trial Logistics & Supply (2011) Fb
Clinical Trial Logistics & Supply (2011) FbClinical Trial Logistics & Supply (2011) Fb
Clinical Trial Logistics & Supply (2011) FbFateja
 
Regulatory affairs by bishnu koirala
Regulatory affairs by bishnu koiralaRegulatory affairs by bishnu koirala
Regulatory affairs by bishnu koiralaBishnu Koirala
 
HealthBIO 2021_Finnish biotech year 2021_Tero Piispanen
HealthBIO 2021_Finnish biotech year 2021_Tero Piispanen HealthBIO 2021_Finnish biotech year 2021_Tero Piispanen
HealthBIO 2021_Finnish biotech year 2021_Tero Piispanen Business Turku
 
HealthBIO 2021_Orion’s new strategy and industry trends seen from a midsize p...
HealthBIO 2021_Orion’s new strategy and industry trends seen from a midsize p...HealthBIO 2021_Orion’s new strategy and industry trends seen from a midsize p...
HealthBIO 2021_Orion’s new strategy and industry trends seen from a midsize p...Business Turku
 
Medical Devices: EU Directives, Guidance Documents, CE Marking Process and IS...
Medical Devices: EU Directives, Guidance Documents, CE Marking Process and IS...Medical Devices: EU Directives, Guidance Documents, CE Marking Process and IS...
Medical Devices: EU Directives, Guidance Documents, CE Marking Process and IS...ComplianceOnline
 
7th Annual Pharmacovigilance (2012) Pp
7th Annual Pharmacovigilance (2012) Pp7th Annual Pharmacovigilance (2012) Pp
7th Annual Pharmacovigilance (2012) PpPiyush Patel
 
Building a link between ectd and xevmpd
Building a link between ectd and xevmpdBuilding a link between ectd and xevmpd
Building a link between ectd and xevmpdQdossier B.V.
 
How to easy manage the product information file EU regulation 1223/09 tips an...
How to easy manage the product information file EU regulation 1223/09 tips an...How to easy manage the product information file EU regulation 1223/09 tips an...
How to easy manage the product information file EU regulation 1223/09 tips an...Giulio Pirotta
 
6th annual pharmacovigilance conference (2011)
6th annual pharmacovigilance conference (2011)6th annual pharmacovigilance conference (2011)
6th annual pharmacovigilance conference (2011)Pranita Nangia
 
5th Annual Stability Testing (2011) Pp
5th Annual Stability Testing (2011) Pp5th Annual Stability Testing (2011) Pp
5th Annual Stability Testing (2011) PpPiyush Patel
 
Collaboration through TaNeDS programme, Keiko Tamai
Collaboration through TaNeDS programme, Keiko Tamai Collaboration through TaNeDS programme, Keiko Tamai
Collaboration through TaNeDS programme, Keiko Tamai Business Turku
 

What's hot (20)

Finnish biotech year, Tero Piispanen
Finnish biotech year, Tero Piispanen Finnish biotech year, Tero Piispanen
Finnish biotech year, Tero Piispanen
 
5th Annual Pharmacovigilance (2010) Ts
5th Annual Pharmacovigilance (2010) Ts5th Annual Pharmacovigilance (2010) Ts
5th Annual Pharmacovigilance (2010) Ts
 
Chapter 3: Putting patients first
Chapter 3: Putting patients firstChapter 3: Putting patients first
Chapter 3: Putting patients first
 
Nick Lawrence CV 2016 v2
Nick Lawrence CV 2016 v2Nick Lawrence CV 2016 v2
Nick Lawrence CV 2016 v2
 
Innovation drives expansion, Titus Gylvin
Innovation drives expansion, Titus Gylvin Innovation drives expansion, Titus Gylvin
Innovation drives expansion, Titus Gylvin
 
Nick lawrence cv 2015 v1
Nick lawrence cv 2015 v1Nick lawrence cv 2015 v1
Nick lawrence cv 2015 v1
 
Tasso, Vanessa, resume, 6-15
Tasso, Vanessa, resume, 6-15Tasso, Vanessa, resume, 6-15
Tasso, Vanessa, resume, 6-15
 
IDMP with PLG
IDMP with PLGIDMP with PLG
IDMP with PLG
 
Clinical Trial Logistics & Supply (2011) Fb
Clinical Trial Logistics & Supply (2011) FbClinical Trial Logistics & Supply (2011) Fb
Clinical Trial Logistics & Supply (2011) Fb
 
Regulatory affairs by bishnu koirala
Regulatory affairs by bishnu koiralaRegulatory affairs by bishnu koirala
Regulatory affairs by bishnu koirala
 
HealthBIO 2021_Finnish biotech year 2021_Tero Piispanen
HealthBIO 2021_Finnish biotech year 2021_Tero Piispanen HealthBIO 2021_Finnish biotech year 2021_Tero Piispanen
HealthBIO 2021_Finnish biotech year 2021_Tero Piispanen
 
HealthBIO 2021_Orion’s new strategy and industry trends seen from a midsize p...
HealthBIO 2021_Orion’s new strategy and industry trends seen from a midsize p...HealthBIO 2021_Orion’s new strategy and industry trends seen from a midsize p...
HealthBIO 2021_Orion’s new strategy and industry trends seen from a midsize p...
 
Medical Devices: EU Directives, Guidance Documents, CE Marking Process and IS...
Medical Devices: EU Directives, Guidance Documents, CE Marking Process and IS...Medical Devices: EU Directives, Guidance Documents, CE Marking Process and IS...
Medical Devices: EU Directives, Guidance Documents, CE Marking Process and IS...
 
Resume 03-31-2015
Resume 03-31-2015Resume 03-31-2015
Resume 03-31-2015
 
7th Annual Pharmacovigilance (2012) Pp
7th Annual Pharmacovigilance (2012) Pp7th Annual Pharmacovigilance (2012) Pp
7th Annual Pharmacovigilance (2012) Pp
 
Building a link between ectd and xevmpd
Building a link between ectd and xevmpdBuilding a link between ectd and xevmpd
Building a link between ectd and xevmpd
 
How to easy manage the product information file EU regulation 1223/09 tips an...
How to easy manage the product information file EU regulation 1223/09 tips an...How to easy manage the product information file EU regulation 1223/09 tips an...
How to easy manage the product information file EU regulation 1223/09 tips an...
 
6th annual pharmacovigilance conference (2011)
6th annual pharmacovigilance conference (2011)6th annual pharmacovigilance conference (2011)
6th annual pharmacovigilance conference (2011)
 
5th Annual Stability Testing (2011) Pp
5th Annual Stability Testing (2011) Pp5th Annual Stability Testing (2011) Pp
5th Annual Stability Testing (2011) Pp
 
Collaboration through TaNeDS programme, Keiko Tamai
Collaboration through TaNeDS programme, Keiko Tamai Collaboration through TaNeDS programme, Keiko Tamai
Collaboration through TaNeDS programme, Keiko Tamai
 

Viewers also liked

EU EOM to the Republic of Lebanon 2009 - Final Report (full)
EU EOM to the Republic of Lebanon 2009 - Final Report (full)EU EOM to the Republic of Lebanon 2009 - Final Report (full)
EU EOM to the Republic of Lebanon 2009 - Final Report (full)Philippe de Bard
 
5 ways to increase your productivity
5 ways to increase your productivity5 ways to increase your productivity
5 ways to increase your productivityLifePower
 
Voorbeelden Succesvolle Employee Driven Innovation (EDI)
Voorbeelden Succesvolle Employee Driven Innovation (EDI)Voorbeelden Succesvolle Employee Driven Innovation (EDI)
Voorbeelden Succesvolle Employee Driven Innovation (EDI)Ben-Anne Wieringa
 
Tarea 3 tecnologia aplicada a la educacion
Tarea 3 tecnologia aplicada a la educacionTarea 3 tecnologia aplicada a la educacion
Tarea 3 tecnologia aplicada a la educacionnicaury Lantigua Rivera
 
Archiving the Airwaves. Accountability of the Dutch Public Broadcasting Syste...
Archiving the Airwaves. Accountability of the Dutch Public Broadcasting Syste...Archiving the Airwaves. Accountability of the Dutch Public Broadcasting Syste...
Archiving the Airwaves. Accountability of the Dutch Public Broadcasting Syste...Jasper Snoeren
 
ATM2016.docx (1)
ATM2016.docx (1)ATM2016.docx (1)
ATM2016.docx (1)Anne Morris
 
Các tiện ích thường thấy trên máy giặt
Các tiện ích thường thấy trên máy giặtCác tiện ích thường thấy trên máy giặt
Các tiện ích thường thấy trên máy giặtDienmaynguoiviet2
 
Elements of Digital Citizenship
Elements of Digital CitizenshipElements of Digital Citizenship
Elements of Digital CitizenshipIan Jake Loquere
 
Jolighting LED Flood Light Catalog
Jolighting LED Flood Light CatalogJolighting LED Flood Light Catalog
Jolighting LED Flood Light CatalogBella Hui
 
Mofakerah presentation-Nov 5,2015
Mofakerah presentation-Nov 5,2015Mofakerah presentation-Nov 5,2015
Mofakerah presentation-Nov 5,2015Eman AL_Qaisi
 
What_it_Takes_to_Model_a_Wiring_Solution
What_it_Takes_to_Model_a_Wiring_SolutionWhat_it_Takes_to_Model_a_Wiring_Solution
What_it_Takes_to_Model_a_Wiring_SolutionMichael Cook
 

Viewers also liked (13)

EU EOM to the Republic of Lebanon 2009 - Final Report (full)
EU EOM to the Republic of Lebanon 2009 - Final Report (full)EU EOM to the Republic of Lebanon 2009 - Final Report (full)
EU EOM to the Republic of Lebanon 2009 - Final Report (full)
 
5 ways to increase your productivity
5 ways to increase your productivity5 ways to increase your productivity
5 ways to increase your productivity
 
Voorbeelden Succesvolle Employee Driven Innovation (EDI)
Voorbeelden Succesvolle Employee Driven Innovation (EDI)Voorbeelden Succesvolle Employee Driven Innovation (EDI)
Voorbeelden Succesvolle Employee Driven Innovation (EDI)
 
Tarea 3 tecnologia aplicada a la educacion
Tarea 3 tecnologia aplicada a la educacionTarea 3 tecnologia aplicada a la educacion
Tarea 3 tecnologia aplicada a la educacion
 
Archiving the Airwaves. Accountability of the Dutch Public Broadcasting Syste...
Archiving the Airwaves. Accountability of the Dutch Public Broadcasting Syste...Archiving the Airwaves. Accountability of the Dutch Public Broadcasting Syste...
Archiving the Airwaves. Accountability of the Dutch Public Broadcasting Syste...
 
SKservices
SKservicesSKservices
SKservices
 
ATM2016.docx (1)
ATM2016.docx (1)ATM2016.docx (1)
ATM2016.docx (1)
 
Các tiện ích thường thấy trên máy giặt
Các tiện ích thường thấy trên máy giặtCác tiện ích thường thấy trên máy giặt
Các tiện ích thường thấy trên máy giặt
 
Elements of Digital Citizenship
Elements of Digital CitizenshipElements of Digital Citizenship
Elements of Digital Citizenship
 
Jolighting LED Flood Light Catalog
Jolighting LED Flood Light CatalogJolighting LED Flood Light Catalog
Jolighting LED Flood Light Catalog
 
Mofakerah presentation-Nov 5,2015
Mofakerah presentation-Nov 5,2015Mofakerah presentation-Nov 5,2015
Mofakerah presentation-Nov 5,2015
 
vipul resume (3)
vipul resume (3)vipul resume (3)
vipul resume (3)
 
What_it_Takes_to_Model_a_Wiring_Solution
What_it_Takes_to_Model_a_Wiring_SolutionWhat_it_Takes_to_Model_a_Wiring_Solution
What_it_Takes_to_Model_a_Wiring_Solution
 

Similar to Hafiz CV 2016

Jacqueline Flounders CV September 2016
Jacqueline Flounders CV September 2016Jacqueline Flounders CV September 2016
Jacqueline Flounders CV September 2016jacqui flounders
 
SRINIVASAN_AResume(2016) for Linked In
SRINIVASAN_AResume(2016) for Linked InSRINIVASAN_AResume(2016) for Linked In
SRINIVASAN_AResume(2016) for Linked InAloka Srinivasan
 
581ce1598f7df.pdf
581ce1598f7df.pdf581ce1598f7df.pdf
581ce1598f7df.pdfCheri Adams
 
Regulatory affairs associate
Regulatory affairs associateRegulatory affairs associate
Regulatory affairs associateJessica Carson
 
Clinical evaluation and the latest 2016 guideline
Clinical evaluation and the latest 2016 guidelineClinical evaluation and the latest 2016 guideline
Clinical evaluation and the latest 2016 guidelineGRCTS
 
1. Introduction to regulatory affairs (2).pptx
1. Introduction to regulatory affairs (2).pptx1. Introduction to regulatory affairs (2).pptx
1. Introduction to regulatory affairs (2).pptxMdJubair13
 
Introducing StratAdviser Ltd
Introducing StratAdviser Ltd Introducing StratAdviser Ltd
Introducing StratAdviser Ltd Jan-Cedric Hansen
 
Company Presentation Final June 2008
Company Presentation   Final June 2008Company Presentation   Final June 2008
Company Presentation Final June 2008lspeid
 
Tajudeen oladele resume_6_sma_11
Tajudeen oladele resume_6_sma_11Tajudeen oladele resume_6_sma_11
Tajudeen oladele resume_6_sma_11Tajudeen Oladele
 
Drug Regulatory Affairs
Drug Regulatory AffairsDrug Regulatory Affairs
Drug Regulatory AffairsNamdeo Shinde
 
CV - David O'Halloran Long Version
CV - David O'Halloran Long VersionCV - David O'Halloran Long Version
CV - David O'Halloran Long VersionDavid O'Halloran
 
Product information for medicinal products in the eu
Product information for medicinal products in the euProduct information for medicinal products in the eu
Product information for medicinal products in the euGlobalCompliancePanel
 
InvenStar* CRC Capabilities
InvenStar* CRC CapabilitiesInvenStar* CRC Capabilities
InvenStar* CRC Capabilitiesinvenstarcrc
 

Similar to Hafiz CV 2016 (20)

Jacqueline Flounders CV September 2016
Jacqueline Flounders CV September 2016Jacqueline Flounders CV September 2016
Jacqueline Flounders CV September 2016
 
SRINIVASAN_AResume(2016) for Linked In
SRINIVASAN_AResume(2016) for Linked InSRINIVASAN_AResume(2016) for Linked In
SRINIVASAN_AResume(2016) for Linked In
 
James Profile
James ProfileJames Profile
James Profile
 
Resume%2520meena11 (002)
Resume%2520meena11 (002)Resume%2520meena11 (002)
Resume%2520meena11 (002)
 
Resume - 2015 April
Resume - 2015 AprilResume - 2015 April
Resume - 2015 April
 
581ce1598f7df.pdf
581ce1598f7df.pdf581ce1598f7df.pdf
581ce1598f7df.pdf
 
Regulatory affairs associate
Regulatory affairs associateRegulatory affairs associate
Regulatory affairs associate
 
Frederic liegeois january 2018 english
Frederic liegeois  january 2018 englishFrederic liegeois  january 2018 english
Frederic liegeois january 2018 english
 
Clinical evaluation and the latest 2016 guideline
Clinical evaluation and the latest 2016 guidelineClinical evaluation and the latest 2016 guideline
Clinical evaluation and the latest 2016 guideline
 
md_qp_prospectus
md_qp_prospectusmd_qp_prospectus
md_qp_prospectus
 
1. Introduction to regulatory affairs (2).pptx
1. Introduction to regulatory affairs (2).pptx1. Introduction to regulatory affairs (2).pptx
1. Introduction to regulatory affairs (2).pptx
 
Introducing StratAdviser Ltd
Introducing StratAdviser Ltd Introducing StratAdviser Ltd
Introducing StratAdviser Ltd
 
Company Presentation Final June 2008
Company Presentation   Final June 2008Company Presentation   Final June 2008
Company Presentation Final June 2008
 
Tajudeen oladele resume_6_sma_11
Tajudeen oladele resume_6_sma_11Tajudeen oladele resume_6_sma_11
Tajudeen oladele resume_6_sma_11
 
Drug Regulatory Affairs
Drug Regulatory AffairsDrug Regulatory Affairs
Drug Regulatory Affairs
 
CV - David O'Halloran Long Version
CV - David O'Halloran Long VersionCV - David O'Halloran Long Version
CV - David O'Halloran Long Version
 
TC 2015 CV
TC 2015 CVTC 2015 CV
TC 2015 CV
 
Product information for medicinal products in the eu
Product information for medicinal products in the euProduct information for medicinal products in the eu
Product information for medicinal products in the eu
 
Biodata for DRA & BD
Biodata for DRA & BDBiodata for DRA & BD
Biodata for DRA & BD
 
InvenStar* CRC Capabilities
InvenStar* CRC CapabilitiesInvenStar* CRC Capabilities
InvenStar* CRC Capabilities
 

Hafiz CV 2016

  • 1. Hafiz Choudhury Email: hafizur.choudhury@outlook.com Mobile: 07837867759 KEYEXPERTISE Regulatory Affairs skills: More than 10 years of Regulatory Affairs experience in CTA, OTC products, MAA, International submissions, Variation, Renewals and License Maintenance and MA transfers Geographic experience: Europe,Asia, Latin America, Middle East and Africa Therapeutic experience: Allergy & Respiratory, Cardiovascular, Metabolic, Hepatology, Inflammation, Neuroscience, Oncology, and Pain Professional experiences RegulatoryAffairs Manager (consultant), PAREXELInternational, Uxbridge, UK May 2015 – present Main responsibilities  Primarily acting as a Parexel Project Lead (PPL) to manage, facilitate and coordinate the delivery of submissions within a given project timelines  Responsible for regulatory submissions throughout the product life cycle globally – EU, North Africa (FSA), Asia, Gulf & LATAM by coordinating with local teams  The planning, coordination and oversight of all processes involved in gaining approvals required in each country for a projects.  Liaising directly with Health Authorities and third party vendors to support regulatory application  Coordinate collection of functional documents in support of regulatory applications  Involved in Project forecasting, activity and submission trackers  Provide regulatory support to Commercial, Medical and Clinical departments through cross- functional interactions in brand and therapeutic area teams  Responsible for the preparation and maintenance of labelling to support MAAs and other post-licensing activities. Ensures that any updates to the Product CCDS are implemented in a timely manner. Liaises with affiliates and/or third parties to co-ordinate translational activities and the subsequent submission of language versions to HA.  Liaises with regulatory, manufacturing and other parties as appropriate, to ensure that updates to the product packaging components are implemented in line with approved labelling for new MAAs or variations affecting the labeling, and in line with required timelines, for products registered globally  Liaises directly with local Affiliates, distributors or agents to define/clarify submission requirements, and follow up on submissions, requests for supplementary information and approvals with specific country and/or regional Sanofi, Guildford, UK RegulatoryAffairs Manager (consultant) August 2014 – April 2015 Main responsibilities  Plan, participate and supervise the technical review and preparation of primary submissions and variations to the MHRAand Ireland,
  • 2.  Manage review and prepare,artwork changes for UK and Ireland i.e. in line with change of ownership, site transfer  Managed the review, preparation, submission and follow-up of regulatory submissions in the UK,  Managing the personal and professional development of colleagues within my team. AMCo (Amdipharm Mercury Company Ltd) RegulatoryAffairs Manager (Consultant) May 2012 –June 2014 Main responsibilities  Management and preparation of rest of the world (ROW) technical and MAtransfers (non- EU) + maintenance of established product licences.  Review and preparation of the safety variations following critical findings from MHRA inspections in UK,Ireland,  Management and coordination of safety variation in EU and the rest of the world (ROW) using affiliate’s and partners on establish products.  Regulatory strategy, project manages regulatory submissions to agreed project targets.  Provide operational regulatory input and guidance in cross-functional teams.  Responsible for the preparation and maintenance of labelling to support MAAs and other post-licensing activities. Ensures that any updates to the Product CCDS are implemented in a timely manner. Liaises with affiliates and/or third parties to co-ordinate translational activities and the subsequent submission of language versions to HA.  Liaises with regulatory, manufacturing and other parties as appropriate, to ensure that updates to the product packaging components are implemented in line with approved labelling for new MAAs or variations affecting the labeling, and in line with required timelines, for products registered globally  Liaises directly with local Affiliates, distributors or agents to define/clarify submission requirements, and follow up on submissions, requests for supplementary information and approvals with specific country and/or regional Pfizer Ltd, Surrey, UK RegulatoryAffairs Manager (Consultant) September 2011 – May 2012 Main responsibilities Manage and Submit Marketing AuthorisationApplications:  National/MRP/Decentralised- Review, co-ordinate and create necessary technicaldata to support UK/Irish submissions e.g. provide national specific module 1 data (PIL, labelling) and module 3  Review and approve proposed regulated documents (SPC, PIL,and Labelling) and associated artwork in line with regulations.  Submit Periodic Safety Update Reports to MHRAand IMB.  Submit MA RenewalApplications PRAinternational (CRO), Reading, UK Senior RegulatoryAffairs Consultant June 2011 - September 2011 Main responsibilities  Review promotional materials for compliance with relevant national and EU legislation and codes of practice  Participate in project team meetings and sponsor teleconferences for initiation activity (regulatory and ethics approvals) as well as maintenance activity in the EU, non-EU countries
  • 3. in Europe  Preparing CTAfor Regulatory authority in EU and non EU-countries Sinclair Pharmaceuticals Ltd, Guildford, UK Senior RegulatoryAffairs Consultant August 2010 - May 2011 Main responsibility  Managing MA transfers in EU,Asia and Mina countries,  Managing the maintenance of license this include renewal, Type IA,B and type II variations  Gap analysis  Advising on other development projects and prospective pre-clinical and clinical data,which may form parts of new IMPD,CTA.  Reviewing labelling and Patient Information leaflets to ensure compliance with current legislation for it to be released in the market  Corresponding with the National health agencies e.g. MHRA,Afssaps and FAMHP Reckitt Benckiser Healthcare,Hull, UK Jan 2010 - July 2010 Senior RegulatoryAffairs Consultant Main responsibility:  Managing the maintenance of OTC license this include renewal,Type IA, B and type II variations  Switch application  Corresponding with the National health agencies e.g. MHRAand Irish Medicines Board  Reviewing labelling and Patient Information leaflets to ensure compliance with current legislation for it to be released in the market  Review of documentations from departments outside Regulatory Affairs i.e. marketing, medical, PV,manufacturing, Quality Assurance,Labelling, Operations functions and R&D. Provides advice with applicable Department Director consultation as to regulatory acceptability of plans for drug development and marketing of the product  Ensuring consistency of readability testing, liaising with external groups (package user-tests vendors), as appropriate. RegulatoryAffairs Manager (consultant), Wyeth, Maidenhead, UK Aug 09 - Dec 09 Main responsibility:  Managed regulatory aspects of projects/products, including applications (CTA, renewals,variation etc) submitted to regulatory agencies.  Developed effective proactive regulatory strategies for global product development, CMC, labelling or promotional issues, and recommends such strategies to RATeam Leader,Team Members and/or supervisor, as appropriate with minor oversight.  Interfaced directly with governmental regulatory personnel, including scientific reviewers, administrative staff and management, to facilitate the review and approval of regulatory applications. Plans and facilitates formal meetings and teleconferences with regulatory authorities.  Reviewed of documentations from departments outside Regulatory Affairs. Provides moderate adv ice with applicable Department Director consultation as to regulatory acceptability of plans for dru g development, CMC, labelling or advertising/promotion through individual as well as RA Team a nd Interdepartmental Project Team contacts.
  • 4. Cephalon, Welwyn Garden City, UK July 08 - July 09 Regulatory Affairs Manager (consultant) Main responsibility:  Prepared Type I and Type II variation applications, Licence renewalapplications,  Approval of UK, Ireland, and EU artworks, change of ownership applications and general regulatory requests to MHRA, IMB etc  Prepare,update and implement labels and leaflets to ensure compliance with marketing authorisations  Worked closely with functional areas throughout the company. Advises functional areas regarding content requirements for regulatory submissions. Critically reviews documents from functional con tributors for consistency and completeness MDS Pharma Services, Winnersh, UK Jan 08 - July 08 RegulatoryAffairs Manager (Consultant) Main responsibilities:  Prepare the clinical trial applications to support exploratory and full development programs, ensuring the documentation meets relevant regulatory requirements. Worked with Clinical teams and advised them on appropriate regulatory strategy when co-coordinating multi-centre clinical trials including countries like Korea,India, Poland and Brazil  Review promotional materials for compliance with relevant national and EU legislation and codes of practice  Participate in project team meetings and sponsor teleconferences for initiation activity (regulatory a nd ethics approvals) as well as maintenance activity in the EU, non-EU countries in Europe, South Africa,Asia and Latin America. Ipsen, Slough Regulatory Affairs Manager (Consultant) July 07 - Dec 07 Main responsibilities:  General regulatory affairs activities as requested. This included post licensing activities including variations Type I and II's. The preparation of clinical trial applications and liaising with regulatory agencies to ensure compliance with requirements and responding to queries.  Managed the EU registration procedures in EU (Centralised or Mutual Recognition)  Prepared and compiled various sections of the CTD with specific emphasis to non-clinical sections of CTD.  Reviewed and commented on protocols/briefing books and reports relating to preclinical, clinical and CMC development.  Worked closely with functional areas throughout the company. Advises functional areas regarding content requirements for regulatory submissions. Critically reviews documents from functional con tributors for consistency and completeness Biogen Idec,Maidenhead/Slough January 07 - June 2007 Regulatory Affairs Manager (consultant) Main responsibilities:
  • 5.  Prepared and/or reviewed and/or submission of marketing authorization Application documents for EU and International Markets (Asia and Latin America)  Worked on development strategy with project teams to develop regulatory strategy for assigned projects.  Liaised with Contract Research Organisations for initial Regulatory submissions and follow-ups on queries and Amendments. Preparation and/or review of standard operating procedures etc I3 Research, Maidenhead, UK Oct 2005 - Dec 2006 Senior Regulatory Affairs Associate Main responsibilities: Co-ordinate Regulatory and ethics submissions  Define a regulatory strategy for the clinical trials.  Provide sponsor/PM with a list of all regulatory documents required to make submissions.  Review and prepare regulatory documents for submissions  Arrange translations of regulatory documents as required  Prepare and make Regulatory and Ethics submissions in coordination of the project team as required.  Track submissions and approvals activities and updates to the Project Teams and Sponsors.  Make submissions of Amendments, IB updates, annual reports etc. as requested by the Sponsors and PM.  Provide PM/Sponsor with regular regulatory status updates as required  Arrange payments of Ethics Committees and Regulatory Authorities  Ensure that regulatory approvals remain in compliance with their authorisations and with current regulatory requirements. This includes scrutinising and making recommendations on all relevant documents e.g. Labelling, patient information leaflets and data sheets to ensure conformance with appropriate current requirements. Foster constructive and professional working relationships with all contacts – internal and external – s o that applications are submitted and approved expeditiously. Sanofi-Aventis UK Regulatory Affairs Specialist January 2005 - Oct 2005 Main responsibilities: Managed company name change by preparing and submitting updated artwork components to the PIU (Product Information Unit) for UK, Ireland and International Markets  Preparation and submission of IA/B variation applications  Preparation and submission of Marketing Authorisation Renewals  Corresponding with the National health agencies e.g. MHRAand Irish Medicines Board  Reviewing labelling and Patient Information leaflets to ensure compliance with current legislation.  Maintaining and updating regulatory databases  Producing technical files for products Regulator-e-AssociatesLtd, April 2004 - Dec 2004 Regulatory Affairs Associate Main responsibilities:  Prepared CMC dossiers including compliance and technical variations.  Reviewed current pharmaceutical journals for day to day relevance to the business.  Handled regulatory activities for our European clients.  Reviewed all current European legislation regarding Clinical Trials Directive and putting together det ailed intelligence documents for training programmes for the company.
  • 6. Other Experiences Over five years experience working within multinational pharmaceutical companies and academic research institutions. I have acquired a strong background in pre-clinical neuropharmacology and physiology during which time I have developed a high level of expertise in both in-vivo and in-vitro experimental techniques. MRI Neurology CEDD, GSK, UK Research Scientist  Preparation of different models of neural disease states.  Testing compounds for Alzheimer's, pain and stroke disease.  Collaborating with various groups, and presented data to internal and externalgroups  Planning, designing and setting up experimental biology studies. Merck Sharp and Dohme, UK Research Scientist  Electro-physiology group to screen candidate drug compounds using patch clamp.  Tested compounds for various groups including pain, anaesthesiology and stroke.  Report writing, and presentation of data to different department within the company. Schering-Plough, UK Research Scientist  Produced live vaccines within a GMP quality control facility. Royal Free hospital & UCLMedical School, London Research Scientist  Investigation of the baroreceptor reflex in the Nucleus Tractus Salaturas (NTS) and looked at c-fos ex pression Training courses attended  Basics of Regulatory Affairs 21 June 2004  Basic Expedition LeadersAward (BELA) November 2002- November 2003 o Planning and preparation method o Instructional and organizational o Navigation o Leadership and party management o Conservation and access o First aid and emergencies  Variation to Marketing Authorisation (MHRAcourse),4 April 2005 Education 1995 - 1999 University of Portsmouth, U.K. BSc (Hons) Pharmacology 1993 - 1995 South-Thames College, U.K BTEC National Diploma in Science Other skills
  • 7.  Skills in using various Regulatory Databases i.e. Novas, GDMS, Pfleet,HATS, GRS  Fluent in English & Bengali References Available on request.